These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8881908)

  • 1. Immunisation policies--successes, failures and the future.
    Miller E
    J Clin Pathol; 1996 Aug; 49(8):620-2. PubMed ID: 8881908
    [No Abstract]   [Full Text] [Related]  

  • 2. Strengthening vaccination policies in Latin America: an evidence-based approach.
    Tapia-Conyer R; Betancourt-Cravioto M; Saucedo-Martínez R; Motta-Murguía L; Gallardo-Rincón H
    Vaccine; 2013 Aug; 31(37):3826-33. PubMed ID: 23357196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paving the way for the introduction of new vaccines into developing countries.
    Chabalgoity JA
    Expert Rev Vaccines; 2005 Apr; 4(2):147-50. PubMed ID: 15889986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Financial requirements of immunisation programmes in developing countries: a 2004-2014 perspective.
    Peny JM; Gleizes O; Covilard JP
    Vaccine; 2005 Aug; 23(37):4610-8. PubMed ID: 15979769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WHO report paints mixed picture of immunisation progress.
    Kapp C
    Lancet; 2002 Nov; 360(9346):1671. PubMed ID: 12457800
    [No Abstract]   [Full Text] [Related]  

  • 6. Advances in the control of vaccine preventable diseases in Ethiopia.
    Wondwossen L; Gallagher K; Braka F; Karengera T
    Pan Afr Med J; 2017; 27(Suppl 2):1. PubMed ID: 28890750
    [No Abstract]   [Full Text] [Related]  

  • 7. Global progress towards universal childhood hepatitis B vaccination, 2003.
    Wkly Epidemiol Rec; 2003 Oct; 78(42):366-70. PubMed ID: 14587209
    [No Abstract]   [Full Text] [Related]  

  • 8. Country recommendations on the inclusion of HPV vaccines in national immunization programmes among high-income countries, June 2006-January 2008.
    Koulova A; Tsui J; Irwin K; Van Damme P; Biellik R; Aguado MT
    Vaccine; 2008 Dec; 26(51):6529-41. PubMed ID: 18805453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The switch to new conjugated vaccines may compromise immunisation coverage for refugees.
    Phillips CB; Patel M
    Med J Aust; 2006 May; 184(9):473. PubMed ID: 16646751
    [No Abstract]   [Full Text] [Related]  

  • 10. Sustainability of National Immunization Programme (NIP) performance and financing following Global Alliance for Vaccines and Immunization (GAVI) support to the Democratic Republic of the Congo (DRC).
    Le Gargasson JB; Breugelmans JG; Mibulumukini B; Da Silva A; Colombini A
    Vaccine; 2013 Apr; 31(15):1886-91. PubMed ID: 23462529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunisation Information Systems - useful tools for monitoring vaccination programmes in EU/EEA countries, 2016.
    Derrough T; Olsson K; Gianfredi V; Simondon F; Heijbel H; Danielsson N; Kramarz P; Pastore-Celentano L
    Euro Surveill; 2017 Apr; 22(17):. PubMed ID: 28488999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The future of routine immunization in the developing world: challenges and opportunities.
    Shen AK; Fields R; McQuestion M
    Glob Health Sci Pract; 2014 Dec; 2(4):381-94. PubMed ID: 25611473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The future of immunisation policy, implementation, and financing.
    Levine OS; Bloom DE; Cherian T; de Quadros C; Sow S; Wecker J; Duclos P; Greenwood B
    Lancet; 2011 Jul; 378(9789):439-48. PubMed ID: 21664676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protecting our public health workers.
    Nat Rev Microbiol; 2013 Feb; 11(2):67. PubMed ID: 23441342
    [No Abstract]   [Full Text] [Related]  

  • 15. Vaccines have sex differential non-targeted heterologous effects: a new dawn in vaccine research.
    Flanagan KL
    Trans R Soc Trop Med Hyg; 2015 Jan; 109(1):1-2. PubMed ID: 25573102
    [No Abstract]   [Full Text] [Related]  

  • 16. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2003 to 2006.
    Menzies R; Turnour C; Chiu C; McIntyre P
    Commun Dis Intell Q Rep; 2008 Jun; 32 Suppl():S2-67. PubMed ID: 18711998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancing access to immunization services and exploiting the benefits of recent innovations in the African region.
    Okeibunor JC; Akanmori BD; Balcha GM; Mihigo R; Vaz RM; Nshimirimana D
    Vaccine; 2013 Aug; 31(37):3772-6. PubMed ID: 23800541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NSW annual immunisation coverage report, 2011.
    Hull B; Dey A; Campbell-Lloyd S; Menzies RI; McIntyre PB
    N S W Public Health Bull; 2012 Dec; 23(9-10):179-86. PubMed ID: 23442995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcutaneous immunization: an overview of advantages, disease targets, vaccines, and delivery technologies.
    Karande P; Mitragotri S
    Annu Rev Chem Biomol Eng; 2010; 1():175-201. PubMed ID: 22432578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Vaccines of the future].
    Nohynek H; Mäkelä P
    Duodecim; 2002; 118(1):99-105. PubMed ID: 12229008
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.